DICHLOROACETIC ACID [Acetic Acid, Dichloro-]
Total Page:16
File Type:pdf, Size:1020Kb
0 Organic Syntheses, Coll. Vol. 2, p.181 (1943); Vol. 19, p.38 (1939). DICHLOROACETIC ACID [Acetic acid, dichloro-] Submitted by Arthur C. Cope, John R. Clark, and Ralph Connor. Checked by R. L. Shriner and Neil S. Moon. 1. Procedure A solution of 250 g. (1.5 moles) of u.s.p. chloral hydrate in 450 cc. of warm water (50–60°) is placed in a 3-l. round-bottomed flask bearing a reflux condenser and thermometer (Note 1). The condenser is temporarily removed and 152.5 g. (1.52 moles) of precipitated calcium carbonate added; this is followed by 2 cc. of amyl alcohol (Note 2) and a solution of 10 g. of technical sodium cyanide in 25 cc. of water. Although the reaction is exothermic, the reaction mixture is heated with a low flame so that it reaches 75° in about ten minutes; at this point heating is discontinued. The temperature continues to rise to 80–85° during five to ten minutes and then drops. As soon as the temperature begins to fall the solution is heated to boiling and refluxed for twenty minutes. The mixture is then cooled to 0–5° in an ice bath, acidified with 215 cc. of concentrated hydrochloric acid (sp. gr. 1.18), and extracted with five 100-cc. portions of ether (Note 3). The combined ether extracts are dried with 20 g. of anhydrous sodium sulfate, the ether is removed by distillation from a steam bath, and the residue is distilled in vacuum from a Claisen flask with a fractionating side arm (Note 4). The yield of dichloroacetic acid, b.p. 99–104°/23 mm., is 172–180 g. (88–92 per cent of the theoretical amount) (Note 5). 2. Notes 1. The amount of hydrogen cyanide evolved is small, and the reaction may be carried out in a hood without any special device for removing this gas. The use of mechanical stirring does not improve the results. 2. Amyl alcohol is added to decrease the amount of foaming. 3. The emulsion which often forms during the ether extraction may be broken by filtering through a fluted filter or with suction. 4. The product decomposes when distilled at atmospheric pressure. 5. The preparation has been carried out with equally good results using double the quantities given above. 3. Discussion Dichloroacetic acid has been prepared by the chlorination of acetic1 or chloroacetic2 acid, by hydrolysis of pentachloroethane,3 from trichloroacetic acid by electrolytic reduction4 or the action of copper,5 and by the action of alkali cyanides on chloral hydrate.6 The method described here is essentially that of Delépine.7 References and Notes 1. Müller, Ann. 133, 159 (1865); Dow Chemical Company, U. S. pat. 1,921,717 [C. A. 27, 5084 (1933)]. 2. Maumené, Compt. rend. 59, 84 (1864). 3. Alais, Froges, and Camargue, Fr. pat. 773, 623 [C. A. 29, 1437 (1935)]. 4. Brand, Ger. pat. 246,661 [C. A. 6, 2496 (1912)]. 5. Doughty and Black, J. Am. Chem. Soc. 47, 1091 (1925); Doughty and Derge, ibid. 53, 1594 (1931). 6. Wallach, Ann. 173, 288 (1874); Pucher, J. Am. Chem. Soc. 42, 2251 (1920); Chattaway and Irving, J. Chem. Soc. 1929, 1038. 7. Delépine, Bull. soc. chim. (4) 45, 827 (1929). Appendix Chemical Abstracts Nomenclature (Collective Index Number); (Registry Number) hydrochloric acid (7647-01-0) ether (60-29-7) sodium cyanide (143-33-9) hydrogen cyanide (74-90-8) sodium sulfate (7757-82-6) copper (7440-50-8) calcium carbonate (471-34-1) chloral hydrate (302-17-0) amyl alcohol (71-41-0) dichloroacetic acid, Acetic acid, dichloro- (79-43-6) pentachloroethane (76-01-7) trichloroacetic acid (76-03-9) Dichloroacetic acid From Wikipedia, the free encyclopedia Jump to: navigation, search Dichloroacetic acid IUPAC name [hide] Dichloroacetic acid Other names[hide] Dichloroethanoic acid Identifiers CAS number 79-43-6 PubChem 6597 ChemSpider 10771217 UNII 9LSH52S3LQ DrugBank DB08809 KEGG C11149 MeSH Dichloroacetate ChEBI CHEBI:36386 ChEMBL CHEMBL13960 RTECS number AG6125000 Jmol-3D images Image 1 SMILES [show] InChI [show] Properties Molecular formula C2H2Cl2O2 Molar mass 128.94 g mol−1 Appearance Colorless liquid Density 1.5634 g/cm3 (20 °C) 9-11 °C, 282-284 K, 48-52 °F Melting point 194 °C, 467 K, 381 °F Boiling point Solubility in water miscible Solubility miscible with ethanol, diethyl ether [1] Acidity (pKa) 1.35[1] Thermochemistry Std enthalpy of -1 o -496.3 kJ·mol [1] formation ΔfH 298 Hazards MSDS MSDS (jtbaker) R-phrases R35 R50 S-phrases (S1/2) S26 S45 S61 1 NFPA 704 3 Related compounds Chloroacetic acid Related chloroacetic acids Trichloroacetic acid Acetic acid Related compounds Difluoroacetic acid Dibromoacetic acid (verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox references Dichloroacetic acid, often abbreviated DCA, is the chemical compound with formula C H Cl 2COOH. It is an acid, an analogue of acetic acid, in which two of the three hydrogen atoms of the methyl group have been replaced by chlorine atoms. The salts and esters of dichloroacetic acid are called dichloroacetates. Salts of DCA have been studied as potential drugs because they inhibit the enzyme pyruvate dehydrogenase kinase.[citation needed] Although preliminary studies have shown DCA can slow the growth of certain tumors in animal studies and in vitro studies, "Available evidence does not support the use of DCA for cancer treatment at this time."[2] Contents • 1 Chemis try and occurre nce • 2 Therap eutic use • 2 . 1 L a c t i c a c i d o s i s • 3 Potenti al cancer applicat ions • 3 . 1 R e s u l t s o f Chemistry and occurrence The chemistry of dichloroacetic acid is typical for halogenated organic acids. It is a member of the chloroacetic acids family. The dichloroacetate ion is produced when the acid is mixed with water. As an acid with a pKa of 1.35,[1] pure dichloroacetic acid is very corrosive and extremely destructive to tissues of the mucous membranes and upper respiratory tract via inhalation.[3] DCA does not occur in nature. It is a trace product of the chlorination of drinking water and is produced by the metabolism of various chlorine-containing drugs or chemicals.[4] DCA is typically prepared by the reduction of trichloroacetic acid. DCA is prepared from chloral hydrate also by the reaction with calcium carbonate and sodium cyanide in water followed by acidifying with hydrochloric acid. Therapeutic use Owing to the highly corrosive action of the acid, only the salts of dichloroacetic acid are used therapeutically, including its sodium and potassium salts, sodium dichloroacetate and potassium dichloroacetate. Lactic acidosis The dichloroacetate ion stimulates the activity of the enzyme pyruvate dehydrogenase by inhibiting the enzyme pyruvate dehydrogenase kinase.[5] Thus, it decreases lactate production by shifting the metabolism of pyruvate from fermentation towards oxidation in the mitochondria. This property has led to trials of DCA for the treatment of lactic acidosis in humans. [6] [7] [8] [9] A randomized controlled trial in children with congenital lactic acidosis found that while DCA was well tolerated, it was ineffective in improving clinical outcomes.[7] A separate trial of DCA in children with MELAS (a syndrome of inadequate mitochondrial function, leading to lactic acidosis) was halted early, as all 15 of the children receiving DCA experienced significant nerve toxicity without any evidence of benefit from the medication.[8] A randomized controlled trial of DCA in adults with lactic acidosis found that while DCA lowered blood lactate levels, it had no clinical benefit and did not improve hemodynamics or survival.[9] Thus, while early case reports and pre-clinical data suggested that DCA might be effective for lactic acidosis, subsequent controlled trials have found no clinical benefit of DCA in this setting. In addition, clinical trial subjects were incapable of continuing on DCA as a study medication owing to progressive toxicities. Potential cancer applications Cancer cells generally express increased glycolysis, because they rely on anaerobic respiration that occurs in the cytosol (lactic acid fermentation) rather than oxidative phosphorylation in the mitochondria for energy (the Warburg effect), as a result of hypoxia that exists in tumors and malfunctioning mitochondria. [10] [11] Usually dangerously damaged cells kill themselves via apoptosis, a mechanism of self-destruction that involves mitochondria, but this mechanism fails in cancer cells. A phase I study published in January 2007 by researchers at the University of Alberta, who had tested DCA on human[12] cancer cells grown in mice, found that DCA restored mitochondrial function, thus restoring apoptosis, allowing cancer cells to self-destruct and shrink the tumor.[13] These results received extensive media attention, beginning with an article in New Scientist titled "Cheap, ‘safe’ drug kills most cancers".[12] Subsequently, the American Cancer Society and other medical organizations have received a large volume of public interest and questions regarding DCA.[14] Clinical trials in humans with cancer have not been conducted in the USA and are not yet final in Canada, emphasizing the need for caution in interpreting the preliminary results. [14] [15] Results of phase II clinical trials In in vitro studies, Evangelos Michelakis of University of Alberta found that in tissue samples from 49 patients, DCA caused depolarization of mitochondria in GBM tissue but not in healthy brain tissue.[16] Five patients with primary GBM were entered into a phase II trial. Three had not responded to several chemotherapies and was considered appropriate for palliative care. Two were newly diagnosed and then went through surgical removal of tumour mass. All of them were treated with DCA and chemotherapy.[16] Of the five patients tested, one of the first three died after three months.